OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,721,364 | +39.8% | 301,325 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $2,661,647 | +950.9% | 294,756 | +303.8% | 0.00% | – |
| Q1 2023 | $253,283 | +52.9% | 72,992 | +7.9% | 0.00% | – |
| Q4 2022 | $165,664 | -11.4% | 67,618 | -0.2% | 0.00% | – |
| Q3 2022 | $187,000 | -23.7% | 67,735 | +12.5% | 0.00% | – |
| Q2 2022 | $245,000 | -75.1% | 60,200 | -73.9% | 0.00% | – |
| Q1 2022 | $983,000 | -58.2% | 230,883 | -8.1% | 0.00% | – |
| Q4 2021 | $2,350,000 | -65.4% | 251,108 | +2.0% | 0.00% | -100.0% |
| Q3 2021 | $6,788,000 | +81.8% | 246,265 | +84.5% | 0.00% | 0.0% |
| Q2 2021 | $3,734,000 | -13.5% | 133,442 | +2.6% | 0.00% | 0.0% |
| Q1 2021 | $4,317,000 | +546.3% | 130,108 | +835.9% | 0.00% | – |
| Q4 2020 | $668,000 | – | 13,902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $9,172,494 | 1.08% |
| BVF INC/IL | 7,611,503 | $18,648,182 | 0.79% |
| Kynam Capital Management, LP | 2,025,234 | $4,961,823 | 0.76% |
| SECTORAL ASSET MANAGEMENT INC | 1,441,805 | $3,532,422 | 0.68% |
| Vivo Capital, LLC | 1,689,515 | $4,139 | 0.48% |
| Cormorant Asset Management, LP | 2,082,000 | $5,101 | 0.34% |
| Monaco Asset Management SAM | 351,517 | $861,217 | 0.26% |
| Newtyn Management, LLC | 360,000 | $882,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 318,926 | $781,369 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 231,633 | $568 | 0.07% |